Dr. Dioszeghy Peter Mononeuropathies
Dr. Dioszeghy Peter Mononeuropathies
2018
Mononeuropathies
Classification of lesions of peripheral nerves
Incomplete
Neurinoma
regeneration
Axonotmesis
The axons lose their continuity but the connective tissue
remain more or less intact and the Schwann cell
basement membrane survives.
The Wallerian degeneration of the distal part of the
nerve is complete, but regeneration is always present
and runs its normal course.
Clinical features:
same like in the neurotmesis
Neurapraxia
Transient loss of conduction without structural
changes, without interruption of the continuity
of any of the nerve components.
Clinical features:
Motor signs: mainly paresis, no muscular atrophy
Sensory signs: mostly subjective (numbness, tingling,
burning), the loss of sensation is rare, the deep sensory
qualities may be affected.
The most frequent causes of the injuries of the nerves
1. Trauma
2. Ischemia
occlusion
compression of arteries
3. Pressure
nerve compression
deformation
of myelin sheath
Diagnosis of nerve lesions
1. Anamnesis
2. Physical examination
2. Special diagnostic methods
•Sweet test (Minor test, Ninhydrin test)
•Electrophysiology
ENG: Motor and sensory nerve conduction studies are
important to ascertain the site and nature of the injury.
EMG: localization, severity of the lesion, signs of
denervation and regeneration (time course),
differentiation of nerve-plexus-root injuries
SENSORY MOTOR
Orthodrom
Antidrom
Signs of denervations
Fibrillation potentials
Clinical features
- weakness: abduction of the arm
- hypoesthesia: lateral surface of shoulder
Ulnar nerve
Clinical features
weakness
- flexion, adduction of wrist
- flexion of ring, little fingers
- abduction of little finger
- adduction of thumb
atrophy
- hypothenar and interossei
clawing of the hand
sensory loss
Places of compression
of ulnar nerve
Radial nerve
• Weekness
extension ('wrist drop'):
wrist, fingers
"park bench paralysis”,
"Saturday night palsy"
Median nerve
"preacher's hand"
Carpal tunnel syndrome
Localisation
compression of median nerve by transverse carpal ligament at wrist
Predisposing factors
constitutional features, fractures, arthritis, pregnancy, diabetes mellitus,
hypothyreosis, sudden increase in weight, gout, strenuous exercise
Clinical features
nocturnal brachialgia paresthetica, pain irradiating into 1-3 fingers, pain upon
pressure on the median nerve, typical sensory loss, hand is swollen, joints are
rigid, atrophy and weakness of the thenar muscles
Treatment
inmobiliztion of wrist, local infiltration with cortisol, decompression
Common peroneal nerve
Causes
Fracture of fibula
Compression
- long lasting kneeling
- crossing of the leg
- plaster cast,
- fibrous band
N. peroneus communis
Clinical features
Weakness dorsiflexion of leg and toes
steppage gait, footdrop
Sensory loss back of the leg
anterior-lateral aspect of sole
Polyneuropathy refers to a disease
characterized by widespread simultaneous
involvement of the peripheral nerves.
Pronounced
Early demyelinisation
demyelinisation „onion bulb”
„onion bulb”
Axonal lesion
Normal
Clinical signs and pathology
The clinical course/prognosis are determined by the underlying
pathology.
Demyelinisation Axonal lesion
• Acute and relapsing course, • Acute and chronic progressive
course
• Rapid and full recovery, • Slow and generally incomplete
recovery,
• Severe paresis, • Severe paresis,
• Lack of significant atrophy, • Prominent atrophy,
• Global areflexia, • Achilles areflexia (patella, upper
extremity reflexes are preserved),
• Motor signs are more pronounced, • Significant sensory simptoms and
signs.
Protocol of clinical evaluation
1. Neurological examination including detailed history
2. Electrophysiological studies
3. Laboratory examinations
4. Genetic studies
5. Histology
The first two steps are the neurological examination and the
electrophysiological studies.
They help to make a rational investigational program, the
special studies can appropriately be applied only after these
examinations.
Locus Gene product Type of genetic
lesion
CMT (Charcot-Marie-Tooth) type 1 (demyelinisation)
CMT 1A 17p11-12 PMP22 dupl/pm
CMT 1B 1q22-23 PMPO pm
CMTX Xq13 connexin 32 pm
CMT type 2 (axonal)
CMT 2A 1p36 ismertlen ismertlen
CMT 2B 3q ismertlen ismertlen
HNPP 17p11-12 PMP22 deletio
CMT 3 17p11-12 PMP22 pm
(Dejerine-Sottas)
PMP22 = peripheriás myelin protein 22 kD
PMP0 = peripheriás myelin protein 0 (28 kD)
Cx32 = Connexin 32
HNPP = Hereditary neuropathy with liability to pressure palsies
Guilllain Barré Syndrome (GBS)
Definition
Acute, autoimmune, polyradiculoneuropathy affecting the
peripheral nervous system, usually triggered by an infectious
process. It exhibits as an ascending paralysis in the legs that
spreads to the upper limbs, face and respiratory muscles.
Variants of GBS syndrome
GUILLAIN-BARRE
SYNDROME
Regional Functional
Demyelinating Axonal
variants variants
Antecedent events
• They usually occur 1 - 3 weeks before the onset of
clinical symptoms.
• The most often reported is a benign upper
respiratory or gastrointestinal infection
(campylobacter jejuni)
Clinical Symptoms and Signs
Paresthesias
• Herald the onset of the disorder in at least 50% of patients
• Distal, symmetrical
• Spreads proximally but seldom extends beyond the ankles
and wrists
Weakness
• Weakness is first noted a few days after the onset of
paresthesias
• It begins in the lower extremities
• Ascends to the upper extremities
Diminished or absent deep tendon reflexes
• One of the earliest findings
Diagnostics
CSF analysis:
• Protein concentration: INCREASED
• Cell count: NORMAL
Electrophysiology:
• Nerve conduction studies
Prognosis
• Mortality: ~ 5 %
• Recover without serious neurological sequels ~ 75 %
• Recovery ensues over 6 to 12 months
• Permanent, substantial neurological sequels: ~ 7 - 15 %
Bilateral foot drop
Intrinsic hand muscle weakness and wasting
Sensory ataxia
Burning dysesthesias
Treatment
Specific therapy
• Plasmaexchange
• IvIg treatment
Supportive care
• Patients with suspected GBS should be hospitalized.
• ICU admissions occurs in ~ 30% of GBS patients.
• Major life-threatening complications:
Respiratory failure
Dysautonomia
Venous thromboembolism
Heterogenious group of polyneuropathies. Common features:
1. Immunmediated neuropathy.
2. Chronic progressive or relapsing course.
Progressive phase: > 4 weeks
Duration: > 2 months
3. Signs:
• Symmetrical
• Motor/Sensory
4. CSF: protein – cell dissociation.
5. Treatment:
• Metilprednisolon
• Immunglobulin
• Plasmaexchange
Alcoholic polyneuropathy
• Pathology: primary axonal neuropathy
• Cause: impaired gastrointestinal absorption
Thiamine deficiency
Reduced aldehide dehydrogenase activity
• Lower extremities > Upper extremities
• Sensory signs:
distal burning paresthesias,
diminished sensation with "stocking-to-glove" distribution.
• Gait ataxia: difficulty walking, history of frequent falls.
• Motor signs: weakness of distal predominance
• Areflexia
• Therapy: abstinence
vitamin B1
Diabetic polyneuropathy
Aetiology
chronic hyperglycaemia
Classification
A. Diffuse Neuropathy
1. Distal symmetric sensory-motor pp.
2. Proximal symmetric motor pp. on the lower extremities
3. Autonomic neuropathy
B. Focal neuropathies
1. Cranial neuropathies
2. Radiculopathy/plexopathy
3. Entrapment neuropathies
Clinical features
Clinical Gyógyszerek
features Antimicrobic Cytostatic Cardiovasc.
Sensori Ethionamid Procarbazin
neuropathy Chloramphenicol Nitrofurazon
Diamino substances
Paresthesia Colistin Cytarabin Propranolol
Streptomycin
Nalidixic acid
Sensorimotor Isoniazid Vincristin Perhexilin
neuropathy Streptomycin Chlorabucil Hydrallazin
Nitrofurentoin Clofirat
Dominanarly Sulphonamidok
motor Amphotericin
Drug induced neuropathy
Clinical Drugs
features
Hypnotic Antirheumatic Others
Sensori Phenelsine Sulfoxon
neuropathy Ergotamin
Thiouracil
Chlorpropamid
Paresthesia Thalidomid Gold Methysergid
Glutethimid Indomethacin Phenytoin
Amitriptylin Ghloroquin Disulfiram
Phenylbutazon Tolbutamid
Sensorimotor Imipramin Chlorpropamid
neuropathy Dapson